Demand for ISOLUTE® SLE+ in cartridge format has increased dramatically over recent years, driven by its implementation by many large companies for the analysis of their Forensic, Clinical and Toxicology samples.
“Biotage is happy to work with customers to create improvements in packaging that ease the processing of large quantities of samples in a small amount of time, minimize the cost of disposal, and ensure product quality. Bench space is often a premium at these labs; the larger packs of ISOLUTE® SLE+ can free up storage space and eliminate excessive laboratory waste. The larger packs are now available for the 400 µL, 1 mL and 2 mL column formats. This is a significant cost saving development for any laboratory processing hundreds or thousands of samples per month” says Paul Roberts, Analytical Product Manager, Biotage AB, Sweden.
ISOLUTE® SLE+ is a modified form of diatomaceous earth, and is used for the extraction of a diverse range of analytes from aqueous samples including biological fluids. Sample extractions are accomplished using a simple load-wait-elute procedure. Method selection can be accomplished in a matter of hours making it an ideal tool for the method development chemist wanting to implement methods quickly and efficiently.
For further information visit www.biotage.com or call: in Europe +46 18 56 57 10, in North America toll free 1 800 446 4752, in Japan +81 422 28 1233, other areas please call +46 18 56 57 10.
For further press information from Biotage please contact: James Churchill, Marketing Communications, Biotage GB Ltd. Distribution Way, Dyffryn Business Park, Ystrad Mynach, Hengoed, Wales CF82 7TS United Kingdom, Tel: +44 (0)1443 811 849 Mobile: +44(0)7875484778 Email: email@example.com
About Biotage Biotage offers solutions, knowledge and experience in the areas of analytical and medicinal chemistry. Customers include the world’s top pharmaceutical and biotechnology companies, as well as leading academic institutes. The company is headquartered in Uppsala, Sweden, with offices in China, Japan, the United Kingdom, the United States and a worldwide network of distributors. Biotage has 272 employees with sales of 462.9 MSEK in 2012. Biotage is listed on the NASDAQ OMX Nordic Stock Exchange. Website: www.biotage.com
Update on Biotage’s COVID-19 Response Plan
Smarter Sample Preparation for Environmental Challenges
How does Biotage Act in the Corona Virus Situation?
Sample Preparation Techniques for Synthetic Benzodiazepines
Good Laboratory Practices Software Upgrade for Biotage® Extrahera™